Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
NCT04242095 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240
Last updated 2026-05-11
Summary
This trial collects research data and samples from patients who experience immunotherapy side effects to store for use in future research studies. Studying research data and samples from patients who experience immunotherapy side effects may help researchers better understand how to predict, prevent, and treat these side effects.
Conditions
- Malignancy
Interventions
- PROCEDURE
-
Biospecimen Collection
Undergo collection of tissue, blood, and stool samples
- OTHER
-
Medical Chart Review
Review of medical records
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Alliance for Clinical Trials in Oncology
lead OTHER
Principal Investigators
-
David Kozono, MD, PhD · Brigham and Women's Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-12
- Primary Completion
- 2026-10-01
- Completion
- 2026-10-01
Countries
- United States
Study Locations
More Related Trials
-
Identification and Evaluation of Circulating Tumor Cells and Tumor Related Rare Cells in Immunotherapy
NCT03434912 ·Status: UNKNOWN
-
Immunotherapy & Me
NCT03347058 ·Status: COMPLETED ·Phase: NA
-
Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer
NCT03827343 ·Status: ACTIVE_NOT_RECRUITING
-
A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy
NCT05669638 ·Status: RECRUITING
-
Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer
NCT00057915 ·Status: COMPLETED ·Phase: PHASE1
-
ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)
NCT06900296 ·Status: NOT_YET_RECRUITING
-
Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs
NCT03984318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
NCT04948619 ·Status: RECRUITING ·Phase: PHASE2
-
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
NCT00001158 ·Status: COMPLETED
-
Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy
NCT07198958 ·Status: NOT_YET_RECRUITING
-
Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer
NCT00023985 ·Status: COMPLETED ·Phase: PHASE1
-
Melanoma Patients Immunized with Natural DenDritic Cells
NCT02993315 ·Status: COMPLETED ·Phase: PHASE3
-
Biological Therapy in Treating Patients With Advanced Cancer
NCT00005956 ·Status: COMPLETED ·Phase: NA
-
DC Vaccination for Postremission Therapy in AML
NCT01734304 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma
NCT00965224 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Resistance Interrogation Study
NCT04243720 ·Status: RECRUITING
-
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
NCT03207854 ·Status: RECRUITING
-
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer
NCT00823524 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tumor Lysate Pulsed-Dendritic Cell Vaccines After High-Dose Chemotherapy for Non-Hodgkin's Lymphoma
NCT00006434 ·Status: COMPLETED ·Phase: PHASE3
-
Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults
NCT02496520 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells
NCT00186316 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT03735589 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands
NCT02203825 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission
NCT01686334 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
NCT04929353 ·Status: UNKNOWN ·Phase: NA